- TRADE NAMES: Duvadilan; Isoxine; Sincen; Vasodilan; Vasolan; Vasosuprina; Voxsuprine; Xuprin
- INDICATIONS: Peripheral vascular disease, Raynaud’s phenomenon
- CLASS: Adrenergic beta-receptor agonist
- HALF-LIFE: N/A
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
